Dai Z, Zhang L, Yu Q, Liu L, Yang M, Fan K. Early Administration of Oseltamivir Within 48 Hours After Onset of Flulike Symptoms Can Reduce the Risk of Influenza B Virus-Associated Pneumonia in Hospitalized Pediatric Patients with Influenza B Vi. Pediatr Infect Dis J. 2020 Feb;39(2):e20-e22
We conducted a retrospective study to identify the risk factors for pneumonia in hospitalized pediatric patients with influenza B infection. Receiving oseltamivir within the first 48 hours of onset and frequent cough was respectively considered as a protective factor and a risk factor for the influenza B virus-associated pneumonia in hospitalized pediatric patients. Early administration of oseltamivir can reduce the risk of influenza B virus-associated pneumonia.
See Also:
Latest articles in those days:
- Phylogenetic Analysis of Highly Pathogenic Avian Influenza H7 Viruses in Australia and New Zealand Suggests Local Viral Evolution 18 hours ago
- AI-Powered Identification of Human Cell Surface Protein Interactors of the Hemagglutinin Glycoprotein of High-Pandemic-Risk H5N1 Influenza Virus 18 hours ago
- Seasonal Influenza Vaccination Uptake and Intentions Among Nursing Students in Hong Kong 18 hours ago
- Intranasal Mosaic H1N1 Live Attenuated Influenza Vaccine Elicits Broad Cross-Reactive Immunity and Protection Against Group 1 and 2 Influenza A Viruses 18 hours ago
- Changing Landscape of Pediatric Influenza in Northern Mexico: A Comparative Clinical and Virological Study 18 hours ago
[Go Top] [Close Window]


